Testing a new test for ciprofloxacin-resistant gonorrhea
Part of Infections clinical trials.
This study is testing a new way to quickly check if gonorrhea bacteria are resistant to the antibiotic ciprofloxacin. If you have a positive gonorrhea test, your leftover sample may be used to see if this new test can help guide better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have tested positive for gonorrhea with a test that is approved by the FDA.
- Your sample (like a swab or urine) must have enough material left over to run additional tests.
- The sample must have been stored and handled correctly so it's still usable for testing.
- The type of sample container or solution must be one that the lab can work with for the special tests.
- Your sample must be clearly labeled with basic information like your age and sex.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new quick test that detects gonorrhea (a sexually transmitted infection) in pregnant women and women with vaginal symptoms. The test gives results fast and could help women get treated quickly if needed.
This study checks whether a specific lab test (the “gyrA assay”) can detect gonorrhea in people who do not have symptoms. It may help clinicians find gonorrhea more quickly and with the right treatment when symptoms aren’t present.
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
This trial is testing whether a lower dose (500 mg) of the antibiotic ceftriaxone works as well as the standard dose (1000 mg) for treating gonorrhea in men. If you have a gonorrhea infection in your throat, rectum, or genitals and are otherwise healthy, you may be able to join.
This trial is testing a new way to use special tests (called integrons) to help doctors decide if they can safely use fewer strong antibiotics for urinary tract infections that are resistant to common treatments. It is for people in the hospital who have a resistant infection and may help reduce side effects and prevent more resistance.
This trial compares two ways of testing for chlamydia and gonorrhea in people who don't have symptoms. It aims to see if faster, point-of-care testing improves outcomes compared to standard lab testing.
Hear when a new Neisseria Gonorrheae Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.